secwatch.observer — SEC 8-K summary
======================================

Issuer:     Histogen Inc. (—)
CIK:        0001383701
Form:       8-K
Filed at:   2023-09-26T23:59:59+00:00
Accession:  0000950170-23-049922
Event type: other_material
Sentiment:  negative
Materiality: 0.95
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Histogen announces liquidation plan; Nasdaq to suspend trading Oct 5, 2023
--------------------------------------------------------------------------

- Board approved plan of dissolution; all clinical programs discontinued and workforce reduced to 2 employees effective Sep 30, 2023.
- Nasdaq notified company on Sep 26, 2023 that it is deemed a 'public shell'; trading suspension effective Oct 5, 2023.
- Company will not request a hearing; delisting and deregistration via Form 25-NSE to follow.
- Stockholders must approve the Plan of Dissolution; no further timeline provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1383701/000095017023049922/0000950170-23-049922-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1383701/000095017023049922/hsto-20230926.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-049922

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer